Brian Hill, MD, PhD of Cleveland Clinic discusses the possibility of a combination between checkpoint inhibitors and CAR T-Cell therapy for CLL treatment at the 58th ASH Annual Meeting in San Diego, CA.
Checkpoint Inhibitors and CAR T-Cell Therapy to be Looked at Closely in CLL
